NEW YORK (GenomeWeb) – Molecular diagnostics firm Rosetta Genomics announced today that it has formed a three-year collaboration with the Moffitt Cancer Center to discover, develop, and commercialize a range of microRNA-based cancer tests.

The alliance combines Rosetta's expertise in developing and commercializing miRNA diagnostics with Moffitt's network of medical oncologists and pathologists, and will focus specifically on areas of unmet medical need.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.